https://www.selleckchem.com/products/yk-4-279.html
Copyright © 2020 Brassart-Pasco, Brézillon, Brassart, Ramont, Oudart and Monboisse.Background and aim Liver transplantation (LT) is a validated treatment for hepatocellular carcinoma (HCC). HCC recurrence occurred between 8 and 20% of patients and lung is the most frequent site. Pulmonary metastases resection (PMR) prolongs survival, however in LT-setting the impact on survival is unclear. To give new lights on this issue, we report the experience of three Italian LT Centers. Methods All consecutive HCC transplanted patients in three I
Me gusta
Comentario
Compartir
